99% Purity Ciprofloxacin Tablet Medicine Ciprofloxacin Hydrochloride HCl Powder Ciprofloxacin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Ciprofloxacin
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Ciprofloxacin
• Name: Ciprofloxacin Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 85721-33-1
• Mf: C17h18fn3o3
• MW: 331.347
• Density: 1.461
• Melting Point: 255-257 C
• Boiling Point: 581.8 C at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 5 Ton/Month

Product Description

99% Purity Ciprofloxacin Tablet Medicine Ciprofloxacin Hydrochloride Hcl Powder Ciprofloxacin

 

Product Description

Product Details

Product Name	Ciprofloxacin
CAS No.	85721-33-1
MF	C17H18FN3O3
MW	331.347
Appearance and shape	White Powder

Ciprofloxacin is a synthetic third-generation quinolone antibacterial drug with broad-spectrum antibacterial activity and good bactericidal effect. The antibacterial activity against almost all bacteria is 2 to 4 times stronger than enoxacin. Enterobacter, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria gonorrhoeae, Streptococcus, Legionella, and Staphylococcus aureus have antibacterial effects. Its antibacterial activity is the strongest among the widely used fluoroquinolones. In addition to its high antibacterial activity against gram-negative bacilli, it also has a good antibacterial effect against Staphylococcus, and its effect against Pneumococcus and Streptococcus is slightly worse than that of Staphylococcus. This product also has inhibitory effects on some mycobacteria, Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, etc.

Application & Function

1.Ciprofloxacin is used for the treatment of Bacterial infection of Respiratory tract, UTI, Uncomplicated Cystitis in Females, GI, Chronic Bacterial Prostatitis, CNS, Immuno compromised patients, Skin, Bone and Joint Infections, Uncomplicated cervical and urethral gonorrhea.
2.Ciprofloxacin has in vitro activity against a wide range of gram-negative and gram-positive organisms.
3.Ciprofloxacin inhibits bacterial DNA gyrase, an enzyme responsible for counteracting excessive supercoiling of DNA during replication or transcription. The mechanism of action of quinolones.
4.Ciprofloxacin is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, organisms resistant to these drugs may be susceptible to Ciprofloxacin. There is no known cross-resistance between ciprofloxacin and other.

Specification